Does Race Influence Quality of Life, Toxicity, or Early Relapse Following Proton Therapy in Men With Prostate Cancer?

2012 ◽  
Vol 84 (3) ◽  
pp. S650
Author(s):  
C.M. Bryant ◽  
B. Hoppe ◽  
R.C. Nichols ◽  
R. Henderson ◽  
W.M. Mendenhall ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Proton Therapy ◽  
Early Relapse

scholarly journals Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate Cancer

2016 ◽  
Vol 2 (4) ◽  
pp. 518-524 ◽  
Author(s):  
Derek T. Lee ◽  
Nancy P. Mendenhall ◽  
Tamara L. Smith ◽  
Christopher G. Morris ◽  
Romaine C. Nichols ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Proton Therapy ◽  
Transurethral Resection ◽  
Patient Reported

Multi-institutional Patient-reported Quality of Life After Proton Therapy for Prostate Cancer Compared to Nontreated Men

2012 ◽  
Vol 84 (3) ◽  
pp. S646-S647
Author(s):  
A.K. Lee ◽  
L.B. Levy ◽  
C.J. Rossi ◽  
D.A. Bush ◽  
S. Choi ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Proton Therapy ◽  
Patient Reported

Patient-reported quality of life in men with TURP undergoing proton therapy for prostate cancer.

2013 ◽  
Vol 31 (6_suppl) ◽  
pp. 220-220 ◽  
Author(s):  
Derek Lee ◽  
Bradford S. Hoppe ◽  
Tamara L. Smith ◽  
Christopher G. Morris ◽  
Romaine Charles Nichols ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Proton Therapy ◽  
Toxicity Assessment ◽  
Gu Toxicity ◽  
Significant Difference ◽  
Patient Reported ◽  
Grade 3

220 Background: We report on quality of life (QOL) and early toxicity following proton therapy (PT) among men with prostate cancer who underwent transurethral resection of the prostate (TURP) prior to treatment. Methods: Between 2006 and 2010, 1,540 patients were treated definitively with PT for prostate cancer at UFPTI and enrolled on a prospective IRB-approved outcomes protocol. One hundred of the men had received a TURP before PT. Baseline comorbidities, medications, expanded prostate index composite (EPIC) score, international prostate symptom score (IPSS), and CTCAE vs.3 toxicity assessment were collected prospectively. The Kaplan-Meier product limit method was used to estimate freedom from toxicity. Results: Men who had TURP prior to PT had lower EPIC scores at baseline and at all followup points for urinary function, urinary incontinence, and urinary summary (Table). The TURP group also had lower EPIC bowel bother, bowel function, and bowel summary at baseline, 6-month, and 1-year followup. EPIC urinary bother, urinary irritation/obstruction, and subscales did not show a statistically significant difference at baseline, but they did show lower scores for the TURP group at variable follow-up time points. The IPSS scores among the TURP group did not show a statistical difference from the non-TURP group, except at the 6-month follow-up time point. Toxicity assessment showed that the 2-year and 3-year cumulative incidence of grade 3 GU toxicity rate in the pretreatment TURP group were 14% and 18%, respectively. Conclusions: Pretreatment TURP was associated with both a high incidence of physician-assessed toxicity and inferior patient-reported QOL scores both before and after PT treatment. Studies investigating QOL and toxicity after specific prostate cancer therapies should stratify patients by pretreatment TURP. Longer follow-up and further evaluation of risk factors for grade 3 GU toxicity among this cohort are needed. [Table: see text]

scholarly journals Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer

2016 ◽  
Vol 95 (1) ◽  
pp. 422-434 ◽  
Author(s):  
Curtis Bryant ◽  
Tamara L. Smith ◽  
Randal H. Henderson ◽  
Bradford S. Hoppe ◽  
William M. Mendenhall ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Proton Therapy ◽  
Image Guided ◽  
Patient Reported

scholarly journals Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger

Cancer ◽  
2012 ◽  
Vol 118 (18) ◽  
pp. 4619-4626 ◽  
Author(s):  
Bradford S. Hoppe ◽  
Romaine C. Nichols ◽  
Randal H. Henderson ◽  
Christopher G. Morris ◽  
Christopher R. Williams ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Proton Therapy ◽  
Erectile Function ◽  
Life Outcomes ◽  
Quality Of Life Outcomes

Patient-reported Quality of Life Following Treatment of Prostate Cancer With Proton Therapy

2012 ◽  
Vol 84 (3) ◽  
pp. S213
Author(s):  
B.S. Hoppe ◽  
R.C. Nichols ◽  
R. Henderson ◽  
W.M. Mendenhall ◽  
C. Williams ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Proton Therapy ◽  
Patient Reported
Sign in / Sign up

Export Citation Format

Share Document